PainReform (PRFX) has released an update.
PainReform Ltd., an Israel-based company, has successfully passed all seven proposals during their Extraordinary General Meeting of Shareholders on August 13, 2024. The shareholders’ approval aligns with the requisites outlined in the company’s Notice and Proxy Statement from July 2024. This significant consensus will be reflected in PainReform’s SEC filings, underlining the company’s strong shareholder support for its strategic direction.
For further insights into PRFX stock, check out TipRanks’ Stock Analysis page.
